针对MMP敏感的巨细胞向的辅酶Q10纳米药物用于类风湿性关节炎治疗
Aasma Akram1,2, Nishat Ara1, Prapanna Bhattarai1
1Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, Texas 77843, United States.
Molecular pharmaceutics
|August 5, 2025
概括
这项研究开发了新型纳米颗粒,可以将辅酶Q10 (CoQ10) 输送到巨细胞,用于类风湿性关节炎 (RA) 治疗. 这些"智能"纳米药物向炎症组织,有效地减少炎症和巨细胞激活.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 风湿性关节炎 (RA) 是一种慢性炎症性疾病,其特点是巨细胞透和激活在突组织中.
- 辅酶Q10 (CoQ10) 具有抗炎性质,但缺乏针对 RA 治疗的向输送.
- 开发有针对性的纳米药物可以提高治疗疗效,减少RA管理中的副作用.
研究的目的:
- 开发一种基于纳米粒子 (NP) 的新型配方,用于向向巨细胞输送辅酶Q10 (CoQ10).
- 设计具有对矩阵金属蛋白酶 (MMP) 响应元素的NP,以增强RA受影响的突中的向.
- 评估CoQ10载荷NP在RA模型中调节巨细胞活性和炎症反应中的治疗潜力.
主要方法:
- 纳米颗粒 (NPs) 采用薄膜水化方法制备,其中包括聚乙烯甘---氨酸乙醇胺 (PEG-pp-PE) 和氨酸 (PS).
- 描述了包括粒子大小,泽塔潜力,药物负载和药物释放动态在内的物理化学性质.
- 实验室研究评估了细胞 (RAW264.7) 和纤维细胞 (NIH3T3) 在MMP存在或不存在的情况下吸收NP,并评估了促炎和抗炎细胞因子和细胞激活标志物的调节.
主要成果:
- 载有CoQ10的NP的颗粒大小小小于200nm,泽塔电位约为-40mV,药物释放持续.
- 与纤维细胞相比,由MMP触发的PEG脱和PS介导的细胞分裂导致巨细胞的NP吸收显著更高,表明对MMP敏感的巨细胞的选择性.
- 含有CoQ10的NP有效抑制了促炎性细胞因子 (TNF-α,IL-6,IL-1β) 的产生,增强了抗炎性细胞因子IL-10,并抑制了巨细胞激活标记物 (CD80,CD86,MHCII) 没有显著的细胞毒性.
结论:
- 开发的对MMP敏感的,针对巨细胞的NP代表了治疗RA的有前途的"智能"纳米药物.
- 通过这些NP来向输送CoQ10有效调节巨细胞表型和炎症信号通路.
- 这种纳米医学方法有可能通过专门作用于炎症关节中的激活巨细胞来改善RA治疗.
更多相关视频
06:46Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
8.9K
07:15In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
Published on: October 20, 2013
9.4K
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
01:20Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
01:23Rheumatic Heart Disease I: Introduction
40
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
40
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35